Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine

By Rothman A.L.   Kanesa-thasan N.   West K.   Janus J.   Saluzzo J.-F.   Ennis F.A.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4694-4699

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

By Kanesa-thasan N.   Sun W.   Kim-Ahn G.   Van Albert S.   Putnak J.R.   King A.   Raengsakulsrach B.   Christ-Schmidt H.   Gilson K.   Zahradnik J.M.   Vaughn D.W.   Innis B.L.   Saluzzo J.-F.   Hoke Jr C.H.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3179-3188

Elsevier

Access to resources Recommend Favorite

Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge

By Men R.   Wyatt L.   Tokimatsu I.   Arakaki S.   Shameem G.   Elkins R.   Chanock R.   Moss B.   Lai C.-J.  

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3113-3122

Elsevier

Access to resources Recommend Favorite

Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice

By Kelly E.P.   Greene J.J.   King A.D.   Innis B.L.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2549-2559

Elsevier

Access to resources Recommend Favorite

Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines

By Velzing J.   Groen J.   Drouet M.T.   van Amerongen G.   Copra C.   Osterhaus A.D.M.E.   Deubel V.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1312-1320

Elsevier

Access to resources Recommend Favorite